• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2表达增加与人类前列腺腺癌细胞的辐射抗性相关。

Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.

作者信息

Anai Satoshi, Tanaka Motoyoshi, Shiverick Kathleen T, Kim Wanju, Takada Satoshi, Boehlein Susan, Goodison Steve, Mizokami Atushi, Rosser Charles J

机构信息

Division of Urology, University of Florida, Jacksonville, Florida 32209, USA.

出版信息

J Urol. 2007 May;177(5):1913-7. doi: 10.1016/j.juro.2007.01.019.

DOI:10.1016/j.juro.2007.01.019
PMID:17437847
Abstract

PURPOSE

Cyclooxygenase-2 functions as a survival factor by protecting cells from apoptosis. We analyzed cyclooxygenase-2 expression in LNCaP-COX-2 and LNCaP-Neo cell lines treated with irradiation.

MATERIALS AND METHODS

LNCaP-COX-2 and LNCaP-Neo cells were treated with 0 to 500 microM celecoxib and a dose response curve was generated. A clonogenic assay was performed in which cells were subjected to irradiation (0 to 6 Gy) with or without celecoxib. Cyclooxygenase-2 protein and other relevant proteins were measured by immunohistochemistry Western blot analysis after irradiation and celecoxib treatment.

RESULTS

The 2 studied cell lines experienced cytotoxic effects of celecoxib in a dose related manner. Clonogenic assays demonstrated that LNCaP-COX-2 cells were significantly more resistant to radiation therapy than LNCaP-Neo cells. Furthermore, the addition of celecoxib sensitized LNCaP-Neo and LNCaP-COX-2 cells to the cytocidal effects of radiation. Moreover, cyclooxygenase-2 over expression was associated with the over expression of pAkt and carbonic anhydrase. In this cell line irradiation alone was associated with increased expression of cyclooxygenase-2 and carbonic anhydrase. Combination therapy with irradiation and celecoxib down-regulated cyclooxygenase-2, pAKT and carbonic anhydrase. LNCaP-Neo cells expressed carbonic anhydrase and pAkt. Irradiation of these cells increased carbonic anhydrase and pAkt expression. Combination therapy with irradiation and celecoxib down-regulated carbonic anhydrase and pAkt.

CONCLUSIONS

Cyclooxygenase-2 expression is also associated with pAkt and carbonic anhydrase expression. Down-regulation of cyclooxygenase-2 by celecoxib is associated with decreased expression of cyclooxygenase-2, pAkt and carbonic anhydrase, and eventual radiation sensitization, which is a phenomenon that may have clinical usefulness.

摘要

目的

环氧化酶-2通过保护细胞免于凋亡而发挥生存因子的作用。我们分析了用辐射处理的LNCaP-COX-2和LNCaP-Neo细胞系中环氧化酶-2的表达。

材料与方法

用0至500微摩尔的塞来昔布处理LNCaP-COX-2和LNCaP-Neo细胞,并绘制剂量反应曲线。进行克隆形成试验,其中细胞在有或没有塞来昔布的情况下接受辐射(0至6 Gy)。在辐射和塞来昔布处理后,通过免疫组织化学和蛋白质印迹分析测量环氧化酶-2蛋白和其他相关蛋白。

结果

所研究的两种细胞系对塞来昔布的细胞毒性作用呈剂量相关方式。克隆形成试验表明,LNCaP-COX-2细胞比LNCaP-Neo细胞对放射治疗的抗性明显更强。此外,添加塞来昔布使LNCaP-Neo和LNCaP-COX-2细胞对辐射的杀伤作用敏感。而且,环氧化酶-2的过表达与pAkt和碳酸酐酶的过表达相关。在该细胞系中,单独辐射与环氧化酶-2和碳酸酐酶的表达增加相关。辐射与塞来昔布联合治疗下调了环氧化酶-2、pAKT和碳酸酐酶。LNCaP-Neo细胞表达碳酸酐酶和pAkt。对这些细胞进行辐射增加了碳酸酐酶和pAkt的表达。辐射与塞来昔布联合治疗下调了碳酸酐酶和pAkt。

结论

环氧化酶-2的表达也与pAkt和碳酸酐酶的表达相关。塞来昔布下调环氧化酶-2与环氧化酶-2、pAkt和碳酸酐酶表达的降低以及最终的放射增敏相关,这是一种可能具有临床应用价值的现象。

相似文献

1
Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.环氧化酶-2表达增加与人类前列腺腺癌细胞的辐射抗性相关。
J Urol. 2007 May;177(5):1913-7. doi: 10.1016/j.juro.2007.01.019.
2
Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.塞来昔布对环氧合酶-2活性的抑制作用在体外不会导致人前列腺癌细胞的放射增敏。
Radiother Oncol. 2007 Feb;82(2):229-38. doi: 10.1016/j.radonc.2006.11.018. Epub 2007 Jan 4.
3
Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.塞来昔布(一种环氧化酶(COX)-2选择性抑制剂)通过对表达不同COX-2水平的人类癌细胞进行COX-2依赖性细胞周期调控来增强放射敏感性。
Cancer Res. 2005 Oct 15;65(20):9501-9. doi: 10.1158/0008-5472.CAN-05-0220.
4
Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.环氧化酶-2抑制剂NS398增强辐射对激素难治性人前列腺癌细胞的抗肿瘤作用。
J Urol. 2003 Nov;170(5):2036-9. doi: 10.1097/01.ju.0000092239.98832.52.
5
The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents.环氧化酶-2在前列腺癌细胞中的表达效应:对细胞毒性药物反应的调节
J Pharmacol Exp Ther. 2008 Mar;324(3):1181-7. doi: 10.1124/jpet.107.131383. Epub 2007 Dec 18.
6
Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax.塞来昔布与电离辐射对前列腺癌细胞的联合作用与促凋亡蛋白Bax无关。
Radiother Oncol. 2009 Mar;90(3):413-21. doi: 10.1016/j.radonc.2008.10.021. Epub 2008 Nov 27.
7
Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.塞来昔布对小鼠前列腺腺癌生长的抑制作用:参与COX - 2抑制的转录因子下调
Prostate. 2006 Feb 15;66(3):257-65. doi: 10.1002/pros.20331.
8
Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.选择性环氧化酶-2抑制剂诱导的肿瘤细胞内在放射敏感性增强
Clin Cancer Res. 2000 Jun;6(6):2513-20.
9
Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.放疗与西乐葆(塞来昔布)联合使用可抑制乳腺和肺部肿瘤的生长。
Am J Clin Oncol. 2003 Aug;26(4):S103-9. doi: 10.1097/01.COC.0000074147.22064.67.
10
Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.塞来昔布通过抑制辐射诱导的细胞核表皮生长因子受体(EGFR)转运和DNA修复诱导肿瘤细胞放射增敏:一种不依赖环氧化酶-2(COX-2)的机制
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):203-12. doi: 10.1016/j.ijrobp.2007.08.065. Epub 2007 Nov 8.

引用本文的文献

1
The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive.OSR9 方案:一种使用来自普通医学的九种老药抑制生长驱动的骨肉瘤治疗新增强策略。
Int J Mol Sci. 2023 Oct 23;24(20):15474. doi: 10.3390/ijms242015474.
2
miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD).微小RNA-620通过靶向15-羟基前列腺素脱氢酶(HPGD)促进肿瘤放射抗性。
Oncotarget. 2015 Sep 8;6(26):22439-51. doi: 10.18632/oncotarget.4210.
3
Study of the effects of cyclooxygenase-2 inhibitor on the promotion of hepatic tumorigenesis in rats fed a high fat diet.
环氧化酶-2抑制剂对高脂饮食喂养大鼠肝脏肿瘤发生促进作用的研究。
J Clin Exp Hepatol. 2015 Mar;5(1):14-21. doi: 10.1016/j.jceh.2014.12.010. Epub 2015 Jan 16.
4
Radiosensitization in prostate cancer: mechanisms and targets.前列腺癌的放射增敏:机制与靶点。
BMC Urol. 2013 Jan 26;13:4. doi: 10.1186/1471-2490-13-4.
5
Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.局部应用双氯芬酸抑制 COX-2 表达通过增强 TRAIL 增强人前列腺腺癌异种移植模型的放射敏感性。
BMC Urol. 2013 Jan 5;13:1. doi: 10.1186/1471-2490-13-1.
6
Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects?抗辐射肿瘤的分子指纹识别:我们能否揪出并改造这些“嫌疑分子”?
BMC Cancer. 2009 Jul 9;9:225. doi: 10.1186/1471-2407-9-225.
7
Clinical use and pharmacological properties of selective COX-2 inhibitors.选择性环氧化酶-2抑制剂的临床应用及药理特性
Eur J Clin Pharmacol. 2008 Mar;64(3):233-52. doi: 10.1007/s00228-007-0400-7. Epub 2007 Nov 13.